Filing Manager
Deep Track Capital, LP
Reporting Manager
Deep Track Biotechnology Master Fund, Ltd.
Symbol
DVAX
Shares outstanding
131,788,785 shares
Disclosed Ownership
17,791,486 shares
Ownership
14%
Form type
SCHEDULE 13D/A
Filing time
19 Feb 2025, 21:51:40 UTC
Date of event
18 Feb 2025
Next filing
25 Aug 2025

Sponsored

Quoteable Key Fact

"Deep Track Capital, LP disclosed 14% ownership in Dynavax Technologies Corporation Common Stock, par value $0.001 per share (DVAX) on 18 Feb 2025."

Quick Takeaways

  • Deep Track Capital, LP filed SCHEDULE 13D/A for Dynavax Technologies Corporation Common Stock, par value $0.001 per share (DVAX).
  • Disclosed ownership: 14%.
  • Date of event: 18 Feb 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 19 Feb 2025, 21:51.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deep Track Biotechnology Master Fund, Ltd. 14% 17,791,486 0 17,791,486 /s/ David Kroin David Kroin, Director 0002015536
Deep Track Capital, LP 14% 17,791,486 0 17,791,486 /s/ David Kroin David Kroin, Managing Member of the General Partner of Deep Track Capital, LP 0001856083
David Kroin 14% 17,791,486 0 17,791,486 /s/ David Kroin David Kroin 0001397513